ReviewFrontiers in oncology2021

Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives.

Giacomo Barchiesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.